World's first intra-nasal vaccine for COVID developed by India gets CDSCO nod

The intra-nasal vaccine for COVID received approval under restricted Use in emergency situations for ages 18 and above for primary two dose schedule, homologous booster doses, Union minister Dr Jitendra Singh said.

Related Keywords

Imphal ,Manipur ,India ,Uttar Pradesh ,Karnataka ,Telangana ,Andhra Pradesh ,New Delhi ,Delhi ,Pune ,Maharashtra ,Bharat ,Jitendra Singh ,Bharat Biotech International Limited ,Union Science ,Central Drugs Standard Control Organisation ,Interactive Research School For Health Affairs ,Department Of Biotechnology ,Suraksha Program ,Technology Ministry ,Science Technology ,National Institute Of Immunology ,Byifp Bureau ,Biotechnology Industry Research Assistance ,Annual General Body Meetingof ,Autonomous Institutions ,National Institute ,Immune Monitoring ,T Cell Immunoassay ,Interactive Research School ,Health Affairs ,Reduction Neutralization ,Bharat Biotech ,Independent Charge ,Biotechnology Institutes ,Coronavirus ,Irst Intra Nasal Vaccine For Covid ,Cdsco ,